Latest News on AHA/ACC Primary Prevention Guidelines

Most cardiovascular diseases and mortality come down to 4 years of unhealthy habits (smoking, poor diet, obesity and sedentarism) and 3 major risk factors (cholesterol, hypertension, and diabetes). 

Novedades en las guías de prevención primaria de la AHA/ACC

Ideal cardiovascular health, defined as absence or control of these 7 factors, is far less frequent than we might believe. It is estimated that 87% of the middle-aged adult population and 95% of people over 60, present at least 4 of these factors.

Recommendations on the calculated risk for decision making when it comes to hypertension and hypercholesterolemia have not seen changes recently. 

In other points, new evidence has been incorporated to the new guidelines. 

  • Aspirin: the prophylactic use of aspirin has been put into question. The new guidelines explicitly warn against the risk in patients over 70 and in patients with increased bleeding risk (prior bleeding, coagulopathy, thrombocytopenia, kidney failure or concomitant use of drugs that will increase bleeding). 

Read also: New Valvular Heart Disease Guidelines with Key TAVI and Mitral Regurgitation Updates.


Aspirin indication as primary prevention in middle aged adults is now a IIB recommendation.

  • Smoking: though significantly reduced, it is estimated 35% of men and 20% of women still smoke. Guidelines insist on the importance of routine questions about smoking habits and strongly advice against it (including vaping). 
  • Nutrition, diet, overweight, and obesity: guidelines recommend higher consumption of vegetables, fruit, legumes, nuts, whole grains, and fish. They also advice against processed meats, refined carbohydrates, and sweet drinks. 
  • Exercise and physical activity: asking about the level of physical activity and advising on optimal levels should be routine.  Guidelines recommend 150 minutes a week of intense to moderate activity, 75 minutes of intense activity or a combination of both. For sedentary patients, any kind of physical activity is better than nothing. 
  • Diabetes: one in every three adults meets the criteria for a prediabetic condition and approximately 10% has been diagnosed with type 2 diabetes. Diet, physical activity and weight control are critical to the development and progress of diabetes. 

Read also: Optimal Medical Treatment Under-used in Vascular Peripheral Disease.


For patients who have been diagnosed, metformin is the first line of treatment, with a IIa indication. Sodium/glucose 2 cotransporter Inhibitors and glucagon antagonists are reserved for diabetic patients and additional risk factors. (class IIb).

Conclusion

The new primary prevention guidelines summarize recommendations for the correct identification and modification of risk factors. Creating multidisciplinary teams to implement these guidelines and committing patients to become our life-long allies in this process depends entirely on us. 

CIR.0000000000000678free

Original Title: The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.

Reference: Vera Bittner. Circulation. 2020;142:2402–2404. DOI: 10.1161/CIRCULATIONAHA.119.040625.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...